nach oben

Erschienen in:

08.05.2020 | Case Report

Recurrent Overt Gastrointestinal Bleeding from Ulcerated Gastric Elastofibroma: Unprecedented Presentation of a Rare Condition

verfasst von: Ilaria Loconte, Mariabeatrice Principi, Giuseppe Ingravallo, Nicola Castellaneta, Enzo Ierardi, Alfredo Di Leo

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Excerpt

Elastofibroma is a benign and uncommon soft-tissue tumor, which is histologically characterized by an excessive accumulation of elastic fibers associated with fibrous tissue. The lesion most commonly occurs between lower scapula and chest wall of elderly people with a female predominance; thus, it is usually reported as “elastofibroma dorsi” [1]. In the scapular region, it is thought to be the result of long-standing mechanical irritation. The diagnosis is based on histological features, especially the specific staining of elastic fibers, and the treatment consists in the surgical removal. …

Järvi O, Saxén E. Elastofibroma dorse. Acta Pathol Microbiol Scand Suppl. 1961;51(Suppl 144):83–4.PubMed

Enjoji M, Sumiyoshi K, Sueyoshi K. Elastofibromatous lesion of the stomach in a patient with elastofibroma dorsi. Am J Surg Pathol. 1985;9(3):233–7.CrossRef

Hobbs CM, Burch CDM, Sobin LH. Elastosis and elastofibromatous change in the gastrointestinal tract a clinicopathologic study of 13 cases and a review of the literature. Am J Clin Pathol. 2004;122(2):232–7. https://doi.org/10.1309/LBGT-CG1Q-CD96-M3NF.CrossRefPubMed

Musso S, Cardot-leccia N, Chevallier A, Myx A, Baldini E, Michiels JF. Elastofibroma of the stomach. Pathol Res Pract. 2003;199(9):637–9. https://doi.org/10.1078/0344-0338-00474.CrossRefPubMed

Kai K, Kusano K, Sakai M, Tabuchi M, Yunotani S, Miyazaki K, et al. Active neovascularization and possible vascular-centric development of gastric and periscapular elastofibromas. Virchows Arch. 2009;454(2):181–8. https://doi.org/10.1007/s00428-008-0722-6.CrossRefPubMed

Lichtmannegger I, Gölder S, Probst A, Dönmez G, Agaimy A, Langer E, et al. Frequency and clinicopathological features of fibroelastotic changes in the gastrointestinal tract. Virchows Arch. 2014;465(3):257–64. https://doi.org/10.1007/s00428-014-1605-7.CrossRefPubMed

Ishida M, Iwai M, Kagotani A, Iwamoto N, Okabe H. Elastofibromatous change of the intestine: report of four lesions from three patients with review of the literature. Int J Clin Exp Pathol. 2014;7(5):2291–7.PubMedPubMedCentral

Kharsa G, Molas G, Potet F, Baglin AC, Vaury P, Grossin M. Colonic elastoma. A pathologic study of 7 cases. Ann Pathol. 1992;12(6):362–6.PubMed

Jiang ZG, Matthew M, Yee EU, Horst D. Elastofibromatous change in association with pneumatosis intestinalis. Am J Gastroenterol. 2017;112(3):1514. https://doi.org/10.1038/ajg.2016.471.CrossRefPubMed

10.

Hayashi K, Ohtsuki Y, Sonobe H, Iwata J, Furihata M, Hikita T, et al. Pre-elastofibroma-like colonic polyp: another cause of colonic polyp. Acta Med Okayama. 1991;45(1):49–53. https://doi.org/10.18926/AMO/32215.CrossRefPubMed

11.

Vesoulis Z, Ravichandran P, Agamanolis D, Roe D. Elastofibromatous polyp of the sigmoid colon - a case report and review of gastrointestinal elastofibromas. Can J Gastroenterol. 2003;17(4):275–7. https://doi.org/10.1155/2003/917073.CrossRefPubMed

12.

Gómez Allende N, Spralja Satalic B, Villarroel Pérez A. Elastofibromatous polyps of the gastrointestinal tract: report of three case and review of the literature. Rev Esp Patol. 2019;52(1):3–10. https://doi.org/10.1016/j.patol.2018.03.005.CrossRefPubMed

13.

Beenen E, Brown M, Gananadha S, Mosse C. Elastofibroma of the pylorus presenting as gastric outlet obstruction: a case report and review of literature. ANZ J Surg. 2016;86(11):946–7. https://doi.org/10.1111/ans.12793.CrossRefPubMed

14.

Curcio G, Ligresti D, Granata A, Chiarello G, Tarantino I, Barresi L, et al. Antral gastric elastofibroma diagnosed by unoof biopsy with endoscopic submucosal dissection technique. Endoscopy. 2015;47(Suppl 1 UCTN):E471–2. https://doi.org/10.1055/s-0034-1392969.CrossRefPubMed

15.

Lau KN, Sindram D, Ahrens WA, Agee N, Martinie JB, Iannitti DA. Gastric elastofibroma. Am Surg. 2010;76(12):14468.

Titel: Recurrent Overt Gastrointestinal Bleeding from Ulcerated Gastric Elastofibroma: Unprecedented Presentation of a Rare Condition
verfasst von: Ilaria Loconte
Mariabeatrice Principi
Giuseppe Ingravallo
Nicola Castellaneta
Enzo Ierardi
Alfredo Di Leo
Publikationsdatum: 08.05.2020
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 3/2020
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-020-00412-0

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Recurrent Overt Gastrointestinal Bleeding from Ulcerated Gastric Elastofibroma: Unprecedented Presentation of a Rare Condition

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Extra-nodal Cytokeratin-Positive Interstitial Reticulum Cell Sarcoma Presenting as a Colonic Polyp: Report of a Rare Case with Review of Literature

Primary B Cell Lymphoma of the Pancreas

May Neutrophil Gelatinase-Associated Lipocalin (NGAL) Level Predict Mortality in Patients with Hepatocellular Carcinoma (HCC)?

The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer

Histone Deacetylase Modifications by Probiotics in Colorectal Cancer

DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie